欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/0497/001
药品名称
Lipidil 145 ONE
活性成分
fenofibrate 145.0 mg
剂型
Film-coated tablet
上市许可持有人
Viatris Healthcare GmbH Lütticher Straße 5 53842 Troisdorf Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Spain (ES)
Belgium (BE)
Luxembourg (LU)
Ireland (IE)
France (FR)
Italy (IT)
Greece (GR)
Finland (FI)
Poland (PL)
Lipanthyl NT 145
Hungary (HU)
LIPANTHYL NT 145 mg filmtabletta
Czechia (CZ)
Slovakia (SK)
LIPANTHYL NT 145 mg
许可日期
2005/04/05
最近更新日期
2024/01/02
药物ATC编码
C10AB05 fenofibrate
申请类型
TypeLevel1:
Line Extension
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier [Article 8.3(i)]
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
common-final-spc-0497-V057
Date of last change:2020/12/03
Final Product Information
|
common-final-pl-0497-V057
Date of last change:2020/12/03
Final SPC
|
common-spc-annotated-fenofibrate 200mg-WS-Feb 2017final
Date of last change:2017/11/03
Final SPC
|
common-spc-annotated-feno 145 mg-WS-Feb 2017final
Date of last change:2017/11/03
Final SPC
|
common-spc-annotated-fenofibrate 67mg-WS-Feb 2017final
Date of last change:2017/11/03
Final SPC
|
common-spc-annotated-fenofibrate-160mg-WS-Feb 2017final
Date of last change:2017/11/03
Final SPC
|
common-spc-annotated-fenofibrate 215 mg-WS-Feb 2017final
Date of last change:2017/11/03
Final SPC
|
common-spc-clean-fenofibrate 200mg-WS-Feb 2017final
Date of last change:2017/11/03
Final SPC
|
common-spc-clean-fenofibrate 67mg-WS-Feb 2017final
Date of last change:2017/11/03
Final SPC
|
common-spc-clean-fenofibrate 145 mg-WS-Feb 2017final
Date of last change:2017/11/03
Final SPC
|
spc-feno all strengths-annotated-WS-Feb 2017final
Date of last change:2017/11/03
Final SPC
|
common-spc-clean-fenofibrate 215 mg- WS- Feb 2017final
Date of last change:2017/11/03
Final SPC
|
common-spc-clean-fenofibrate-160mg-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
common-pl-annotated-fenofibrate 145 mg-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
common-pl-annotated-fenofibrate 67mg-WS-Feb 2017final
Date of last change:2017/11/03
Final SPC
|
spc-fenofibrate all strengths-clean-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
common-pl-annotated-fenofibrate 160 mg-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
common-pl-annotated-fenofibrate 215 mg-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
common-pl-annotated-fenofibrate 200mg-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
common-pl-clean-fenofibrate 145 mg-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
common-pl-clean-fenofibrate 160 mg-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
common-pl-clean-fenofibrate 67mg-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
common-pl-clean-fenofibrate 215 mg-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
common-pl-clean-fenofibrate 200mg-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
pl-fenofibrate all strengths-annotated-WS-Feb 2017final
Date of last change:2017/11/03
Final PL
|
pl-fenofibrate all strengths-clean-WS-Feb 2017final
Date of last change:2017/11/03
Final Labelling
|
DE-H-497 et al-II-23 et al_Final Outer and Inner labelling 145mg
Date of last change:2010/03/18
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase